{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:09Z","timestamp":1786988049057,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejim.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T13:34:22Z","timestamp":1632144862000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Recent advances in pericarditis"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-5866","authenticated-orcid":false,"given":"Emanuele","family":"Bizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7240-3920","authenticated-orcid":false,"given":"Chiara","family":"Picchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3455-7304","authenticated-orcid":false,"given":"Greta","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.09.002_bib0001","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100769","article-title":"Acute Pericarditis: Aetiologic Diagnosis and Practical Aspect of the Management","volume":"46","author":"Bouriche","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ejim.2021.09.002_bib0003","article-title":"What is the normal composition of pericardial fluid?","author":"Buoro","year":"2020","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccm.2012.11.006","article-title":"The Light criteria: the beginning and why they are useful 40 years later","volume":"34","author":"Light","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ejim.2021.09.002_bib0005","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1136\/heartjnl-2018-314574","article-title":"Contemporary biochemical analisys of normal pericardial fluid","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2021.09.002_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jclinpath-2019-205788","article-title":"Comparison between optical microscopy and automation for cytometric analysis of pericardial fluids in a cohort of adult subjects undergoing cardiac surgery","volume":"72","author":"Buoro","year":"2019","journal-title":"J Clin Pathol"},{"issue":"27","key":"10.1016\/j.ejim.2021.09.002_bib0007","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJM199912303412704","article-title":"Long-term follow-up of idiopathic chronic pericardial effusion","volume":"341","author":"Sagrist\u00e0-Sauleda","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0008","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/heartjnl-2018-313532","article-title":"Outcomes of idiopathic chronic large pericardial effusion","volume":"105","author":"Imazio","year":"2019","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2459\/JCM.0000000000000720","article-title":"Is pericardial effusion a negative prognostic marker? Meta-analysis of outcomes of pericardial effusion","volume":"20","author":"De Filippo","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"7","key":"10.1016\/j.ejim.2021.09.002_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11886-017-0867-5","article-title":"Pericardial Effusion and Cardiac Tamponade in the New Millennium","volume":"19","author":"Hoit","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0011","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pcad.2016.12.009","article-title":"Pericardial Effusions: Causes, Diagnosis, and Management","volume":"59","author":"Vakamudi","year":"2017","journal-title":"Prog Cardiovasc Dis."},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0012","first-page":"615","article-title":"Tuberculous and Infectious Pericarditis","volume":"35","author":"Chang","year":"2017","journal-title":"Cardiol Clin"},{"issue":"7","key":"10.1016\/j.ejim.2021.09.002_bib0013","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.ejim.2021.09.002_bib0014","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/heartjnl-2018-314528","article-title":"Pericardial diseases in patients with hypothyroidism","volume":"105","author":"Chahine","year":"2019","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ejim.2021.09.002_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11936-018-0654-7","article-title":"Pericardial Disease in Cancer Patients","volume":"20","author":"Ghosh","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0016","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jtho.2019.02.026","article-title":"Immune Checkpoint Inhibitor-Associated Pericarditis","volume":"14","author":"Altan","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.ejim.2021.09.002_bib0017","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10554-020-01784-x","article-title":"Comprehensive review of pericardial diseases using different imaging modalities","volume":"36","author":"Fadl","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.ejim.2021.09.002_bib0018","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/ehs372","article-title":"Management of pericardial effusion","volume":"34","author":"Imazio","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0019","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.chest.2020.07.039","article-title":"Clinical Presentation and Outcomes of Acute Pericarditis in a Large Urban Hospital in the United States of America","volume":"158","author":"Vecchi\u00e9","year":"2020","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.ejim.2021.09.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2013.06.023","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography","volume":"26","author":"Klein","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.ejim.2021.09.002_bib0021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.amjms.2020.10.012","article-title":"Recurrence of Pericardial Effusion After Pericardiocentesis: Does Catheter-Induced Acute Pericardial Inflammation Play a Role?","volume":"361","author":"Lazaros","year":"2021","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0022","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pcad.2016.12.008","article-title":"Constrictive Pericarditis: A Practical Clinical Approach","volume":"59","author":"Miranda","year":"2017","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.ejim.2021.09.002_bib0023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14503\/THIJ-16-5772","article-title":"Surgical Treatment of Constrictive Pericarditis","volume":"44","author":"Depboylu","year":"2017","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.ejim.2021.09.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2021.02.020","article-title":"Pericardiectomy for Constrictive Pericarditis: Analysis of Outcomes","author":"Liu","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"10.1016\/j.ejim.2021.09.002_bib0025","first-page":"487","article-title":"The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis","volume":"21","author":"Perricone","year":"2019","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0026","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/ajm.AJM_78_17","article-title":"Cardiac manifestations of Familial Mediterranean fever","volume":"7","author":"Alsarah","year":"2017","journal-title":"Avicenna J Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00296-017-3854-7","article-title":"Cardiovascular disease in patients with autoinflammatory syndromes","volume":"38","author":"Hintenberger","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00296-017-3853-8","article-title":"Cardiac disease in familial Mediterranean fever","volume":"38","author":"Erken","year":"2018","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.ejim.2021.09.002_bib0029","first-page":"97","article-title":"Pericarditis - Clinical presentation and characteristics of a pediatric population","volume":"38","author":"Perez-Brand\u00e3o","year":"2019","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/j.ejim.2021.09.002_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-015-0057-1","article-title":"Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever","volume":"13","author":"Kilic","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ejim.2021.09.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8562485","article-title":"Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-\u03b1 Receptor- Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network","volume":"2020","author":"Gaggiano","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0032","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00247-019-04536-9","article-title":"Autoinflammatory diseases in childhood, part 1: monogenic syndromes","volume":"50","author":"Navallas","year":"2020","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0033","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1756-185X.13029","article-title":"Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant","volume":"20","author":"Camprub\u00ed","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0034","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.semarthrit.2013.12.002","article-title":"The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up","volume":"43","author":"Cantarini","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ejim.2021.09.002_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12016-020-08825-2","article-title":"Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge","volume":"61","author":"Yang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0036","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and Management of the Cryopyrin- Associated Periodic Syndromes (CAPS): What Do We Know Today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0037","first-page":"123","article-title":"A novel mutation in the CIAS1\/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes","volume":"32","author":"Insalaco","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2021.09.002_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.619257","article-title":"IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives","volume":"11","author":"Malcova","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0039","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5114\/reum.2020.96688","article-title":"Familial Mediterranean fever: What associations to screen for?","volume":"58","author":"Bouomrani","year":"2020","journal-title":"Reumatologia"},{"key":"10.1016\/j.ejim.2021.09.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0041","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijcard.2004.06.012","article-title":"Recurrent idiopathic pericarditis: familial occurrence","volume":"102","author":"Brucato","year":"2005","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2021.09.002_bib0042","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11739-019-02041-3","article-title":"Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis","volume":"14","author":"Lazaros","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"2","key":"10.1016\/j.ejim.2021.09.002_bib0043","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjcard.2006.01.086","article-title":"Long-term outcomes in difficult-to-treat patients with recurrent pericarditis","volume":"98","author":"Brucato","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0044","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00247-019-04544-9","article-title":"Autoinflammatory diseases in childhood, part 2: polygenic syndromes","volume":"50","author":"Navallas","year":"2020","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0045","first-page":"45","article-title":"Therapy for recurrent acute pericarditis: a rheumatological solution?","volume":"24","author":"Brucato","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0046","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2174\/1381612824666180116095658","article-title":"Protogerou AD, Vlachoyiannopoulos P. The Role of Colchicine in the Treatment of Autoinflammatory Diseases","volume":"24","author":"Liantinioti","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0047","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.09.002_bib0048","doi-asserted-by":"crossref","DOI":"10.23736\/S0031-0808.21.04210-5","article-title":"Recurrent pericarditis: an update on diagnosis and management","author":"Vecchi\u00e8","year":"2021","journal-title":"Panminerva Med"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0049","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1755-5922.12226","article-title":"Colchicine for prevention and treatment of cardiac diseases: A meta-analysis","volume":"35","author":"Papageorgiou","year":"2017","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.ejim.2021.09.002_bib0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ejim.2021.09.002_bib0051","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1002\/jcp.27436","article-title":"Inflammation and pericarditis: Are neutrophils actors behind the scenes?","volume":"234","author":"Bonaventura","year":"2019","journal-title":"J Cell Physiol"},{"issue":"28","key":"10.1016\/j.ejim.2021.09.002_bib0052","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ejim.2021.09.002_bib0053","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/heartjnl-2019-316481","article-title":"Acute recurrent pericarditis: from pathophysiology towards new treatment strategy","volume":"106","author":"Cacoub","year":"2020","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0054","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-019-1190-4","article-title":"Noutsias M. Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome","volume":"19","author":"Lutschinger","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"1-3","key":"10.1016\/j.ejim.2021.09.002_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2004.07.011","article-title":"Effects of glucocorticoids on gene transcription","volume":"500","author":"Hayashi","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.ejim.2021.09.002_bib0056","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/14779072.2018.1510315","article-title":"Advances in medical therapy for pericardial diseases","volume":"16","author":"Galluzzo","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1 Suppl","key":"10.1016\/j.ejim.2021.09.002_bib0057","first-page":"54S","article-title":"Characterizing the impact of renal impairment on the clinical pharmacology of biologics","volume":"52","author":"Meibohm","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0058","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-9236(03)00094-8","article-title":"Pharmacokinetics of anakinra in subjects with different levels of renal function","volume":"74","author":"BB","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.ejim.2021.09.002_bib0059","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/heartjnl-2020-317187","article-title":"Interleukin-1 inhibition with anakinra: a valuable ally to reverse constrictive pericarditis?","volume":"106","author":"Lazaros","year":"2020","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.ejim.2021.09.002_bib0060","first-page":"888","article-title":"Efficacy of anakinra for idiopathic and non-idiopathic pericarditis refractory or intolerant to conventional therapy","volume":"9","author":"Shaukat","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ejim.2021.09.002_bib0061","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.amjcard.2020.03.041","article-title":"Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis","volume":"127","author":"Khayata","year":"2020","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0062","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0000000000000847","article-title":"Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis","volume":"76","author":"Wohlford","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18","key":"10.1016\/j.ejim.2021.09.002_bib0063","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejim.2021.09.002_bib0064","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487319879534","article-title":"Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study","volume":"27","author":"Imazio","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2021.09.002_bib0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00296-011-2096-3","article-title":"Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations","volume":"32","author":"Kaiser","year":"2012","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.ejim.2021.09.002_bib0066","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14787210.2018.1483238","article-title":"Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs","volume":"16","author":"Goletti","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ejim.2021.09.002_bib0067","series-title":"Clinical and Research Information on Drug-Induced Liver Injury [Internet]","year":"2020"},{"issue":"7","key":"10.1016\/j.ejim.2021.09.002_bib0068","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0091270009351882","article-title":"Safety and pharmacokinetics of subcutaneously administered rilonacept in patients with well-controlled end- stage renal disease (ESRD)","volume":"50","author":"Radin","year":"2010","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.ejim.2021.09.002_bib0069","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/art.38699","article-title":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis","volume":"66","author":"Ilowite","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.ejim.2021.09.002_bib0070","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ejim.2021.09.002_bib0071","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2012.09.009","article-title":"Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study","volume":"34","author":"Hoffman","year":"2012","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0072","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ejim.2021.09.002_bib0073","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40261-013-0127-4","article-title":"Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: A randomized study in healthy subjects","volume":"33","author":"Chioato","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejim.2021.09.002_bib0074","doi-asserted-by":"crossref","first-page":"0","DOI":"10.2165\/11599820-000000000-00000","article-title":"Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1\u03b2 monoclonal antibody","volume":"51","author":"Chakraborty","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejim.2021.09.002_bib0075","doi-asserted-by":"crossref","unstructured":"Annex I. IFLA J. 20, 338\u2013340 (1994).","DOI":"10.1177\/034003529402000315"},{"key":"10.1016\/j.ejim.2021.09.002_bib0076","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejim.2021.09.002_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42358-020-0117-1","article-title":"Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant\/unresponsive familial Mediterranean fever","volume":"60","author":"S\u0105hin","year":"2020","journal-title":"Adv. Rheumatol."},{"key":"10.1016\/j.ejim.2021.09.002_bib0078","first-page":"668","article-title":"Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups","volume":"36","author":"Feist","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejim.2021.09.002_bib0079","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/17512433.2017.1338946","article-title":"Pharmacological treatment options for cryopyrin-associated periodic syndromes","volume":"10","author":"Landmann","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejim.2021.09.002_bib0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","article-title":"Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study","volume":"76","author":"Gattorno","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejim.2021.09.002_bib0081","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejim.2021.09.002_bib0082","doi-asserted-by":"crossref","first-page":"167","DOI":"10.24953\/turkjped.2020.02.001","article-title":"Canakinumab in colchicine resistant familial mediterranean fever and other pediatric rheumatic diseases","volume":"62","author":"\u00c7akan","year":"2020","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.ejim.2021.09.002_bib0083","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1047951119000672","article-title":"Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab","volume":"29","author":"Ep\u00e7a\u00e7an","year":"2019","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ejim.2021.09.002_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-020-00438-5","article-title":"Failure of anti Interleukin-1 \u00df monoclonal antibody in the treatment of recurrent pericarditis in two children","volume":"18","author":"Signa","year":"2020","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.ejim.2021.09.002_bib0085","first-page":"1494","article-title":"Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up","volume":"57","author":"Kougkas","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2021.09.002_bib0086","article-title":"A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option","author":"Gupta","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"10.1016\/j.ejim.2021.09.002_bib0087","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FJC.0000000000000839","article-title":"Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety","volume":"76","author":"Correia","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ejim.2021.09.002_bib0088","doi-asserted-by":"crossref","DOI":"10.23736\/S0031-0808.21.04198-7","article-title":"Management of acute and recurrent pericarditis in pregnancy","author":"Serati","year":"2021","journal-title":"Panminerva Med"},{"key":"10.1016\/j.ejim.2021.09.002_bib0089","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.612259","article-title":"Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World. Data From the FAERS Database and a Systematic Review","volume":"11","author":"Carnovale","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.ejim.2021.09.002_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2459\/JCM.0000000000000904","article-title":"Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins","volume":"21","author":"Orabona","year":"2020","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"12","key":"10.1016\/j.ejim.2021.09.002_bib0091","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors","volume":"56","author":"Youngstein","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ejim.2021.09.002_bib0092","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10875-017-0389-3","article-title":"Placental Transfer of Canakinumab in a Patient with Muckle-Wells Syndrome","volume":"37","author":"Egawa","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ejim.2021.09.002_bib0093","series-title":"Drugs and Lactation Database (LactMed) [Internet]","year":"2021"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:19Z","timestamp":1760607319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521003022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":93,"alternative-id":["S0953620521003022"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.09.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in pericarditis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}